Current inflammatory bowel disease (IBD) treatments including non-biological, biological,
and nutritional therapies aim to achieve remission and mucosal healing. Treatment efficacy …

Background The gut microbiota has been implicated in the pathogenesis of inflammatory
bowel disease (IBD), with Faecalibacterium prausnitizii associated with protection, and …

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's
disease (CD), is characterized by relapse and remission alternately. It remains a great …

Background The concept of an altered collective gut microbiota rather than identification of a
single culprit is possibly the most significant development in inflammatory bowel disease …

Background & Aims Altering the intestinal microbiota has been proposed as a treatment for
inflammatory bowel diseases (IBDs), but there are no established associations between …

Background Intestinal bacteria produce metabolites and by‐products necessary for
homeostasis. Imbalance in this equilibrium is linked to multiple pathologies including …

Two different conditions are included in inflammatory bowel disease (IBD), Crohn's disease
(CD) and ulcerative colitis (UC), being distinguished by chronic recurrence of gut …

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
chronic immune-mediated inflammatory disorder of the gastrointestinal tract that is closely …

Inflammatory bowel disease (IBD) is an autoimmune disease associated with dysbiosis
within the gastrointestinal tract. Characteristic taxonomic shifts of microbial populations are …

Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal disease
characterized by weight loss, abdominal pain, and bloody diarrhea. The number of affected …